Tim Showalter
@TimShowalter1
Followers
1K
Following
2K
Media
14
Statuses
348
Radiation oncologist; Artera clinical development team
Charlottesville, VA
Joined May 2018
RT @tjroycemd: In this episode we chat w @othman CEO/cofounder @Color - give us a listen for a story of impact and inspiration for how….
podcasts.apple.com
Podcast Episode · HealthTech Remedy · 05/21/2025 · 44m
0
3
0
RT @arteraAI: We’re proud to have @Benioff on Artera’s board, helping shape how AI transforms precision medicine. Check out his latest int….
chiefexecutive.net
Salesforce founder and CEO Marc Benioff led the cloud computing revolution. Now he wants to bring business into an entirely new era of augmented humans, unlimited digital workforces and nothing less...
0
3
0
RT @DrChoueiri: Congratulations to our friends and colleagues @arteraAI —their multimodal #ArtificialInteligence platform is revolutionary….
0
11
0
RT @FabioSchutz78: Dr. @TimShowalter1 from @arteraAI presented the data from prostate cancer and discussed possibilities of integrating tis….
0
8
0
RT @TiansterZhang: Can we take lessons learned from #prostatecancer into #kidneycancer? .@TimShowalter1 says yes!. @kidneycan @kidneycancer….
0
6
0
Thank you for the invitation to share the potential impact we can make together for patients with #RCC #KCRS23 @arteraAI.
Elegant talk on how #AI can guide development of biomarkers in #RCC by @TimShowalter1 .#KCRS23 @OncoAlert @kidneycan
0
1
10
So excited to take on this exciting role with a tremendous team of new friends and some old colleagues! @NGThaker_XRT @dougfloramd @scottpenberthy.
ArteraAI is proud to announce that our own Tim Showalter MD, MPh, is part of the groundbreaking new academic journal - the only peer-reviewed research journal dedicated to the advancement of #AI applications in clinical & precision #oncology:
3
4
27
Amazing work with direct clinical impact! Congrats to @DrSpratticus @NRGonc and the team at @arteraAI.
This report used data derived and validated from completed randomized phase III trials to demonstrate that an AI-based predictive model could identify pts with predominately intermediate-risk #ProstateCancer who are likely to benefit from short-term androgen deprivation therapy.
0
3
10
RT @arteraAI: Are you passionate about #artificialintelligence and innovation in medical care? Join our team!. Are you looking to make a di….
0
2
0
So much fun getting to be a shark for this! Exciting to see the potential impact of AI in brachytherapy. Congratulations to all three of the presenters for compelling proposals and pitches.
Shark tank at ABS#2023 presentation on Chat GPT for brachy education @TimShowalter1 @PranshuMohindra
0
2
19
RT @Sushilberiwal: Shark tank at ABS#2023 presentation on Chat GPT for brachy education @TimShowalter1 @PranshuMohindra .
0
1
0
Congrats to Kara and the UVA team on completing the trial! Very excited to see the great results.
@romano_kara found BrachyGel packing is preferred by brachytherapists & patients with no difference in dose to the cervix or OAR! #ABSBrachy23
1
1
14
RT @arteraAI: Did you catch Tim Showalter's presentation at #BiomarkersSeries23? 🇬🇧. Members of the Artera team met with attendees to discu….
0
1
0
RT @arteraAI: The Artera team is heading to #BiomarkersSeries23 2/27-2/28 in Manchester. 🇬🇧. Don't miss Dr. Tim Showalter's presentation "P….
0
2
0
RT @DrLesterColl: 🏎️ FORMULA 509 @DrPaulNguyen #GU23 #pcsm @OncoAlert. Salvage RT (med dose 68.4 Gy, 26% nodes tx) w 6 mos ADT ±intensifica….
0
11
0
RT @arteraAI: #ArteraAI is at #GU23!. Don't miss today's presentation with @DrSpratticus, as he shares results from six phase III randomize….
0
3
0
RT @IBCradiation: Thrilled to see a great turnout for the amazing IBC update from the incomparable @FilipaLynce @IBC_DanaFarber highlightin….
0
9
0